Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;27(8):1175-1176.
doi: 10.1016/j.cmi.2021.01.025. Epub 2021 Feb 5.

Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al

Affiliations
Comment

Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al

David Koeckerling et al. Clin Microbiol Infect. 2021 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Immunosuppression in patients with severe coronavirus disease 2019 (COVID-19): a balancing act.

Comment on

References

    1. Tleyjeh I.M., Kashour Z., Damlaj M., Riaz M., Tlayjeh H., Altannir M. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(2):215–227. doi: 10.1016/j.cmi.2020.10.036. - DOI - PMC - PubMed
    1. NHS patients to receive life-saving COVID-19 treatments that could cut hospital time by 10 days-GOV.UK n.d. https://www.gov.uk/government/news/nhs-patients-to-receive-life-saving-c... (accessed 9 January 2021).
    1. Rambaut A., Loman N., Pybus O., Barclay W., Barrett J., Carabelli A. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations—SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology—Virological. https://virological.org/t/preliminary-genomic-characterisation-of-an-eme... n.d.
    1. European Centre for Disease Prevention and Control . 2020. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom.
    1. Tonkin-Hill G., Martincorena I., Amato R., Lawson A.R.J., Gerstung M., Johnston I. Patterns of within-host genetic diversity in SARS-CoV-2. The COVID-19 genomics UK (COG-UK) consortium. 2020. - DOI - PMC - PubMed

Substances

LinkOut - more resources